NOVOCURE INC.

Lobbying for NOVOCURE INC.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $110,000.00 expenses · posted Apr 16, 2025

Bills named in this filing 2

Lobbying activity 2

Medicare/Medicaid

General Medicare Issues. H.R.1691/S.5349 - Ensuring Patient Access to Critical Breakthrough Products Act of 2024.

Veterans

Veterans Affairs / Veterans Health Administration (VHA) issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.